Invesco
GRTX

Invesco’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Invesco’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-157,653
Closed -$27.6K – 3911
2023
Q3 		$27.6K Buy
157,653
+146,814
+1,354% +$182K ﹤0.01% 3840
2023
Q2 		$33.8K Buy
+10,839
New +$32.2K ﹤0.01% 3839

Other funds holding GRTX

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco's GRTX Position: Q4 2023 in Review

Invesco sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2023, closing a stake of 157,653 shares — an estimated $27.6K sold.

Invesco first reported a position in GRTX in Q2 2023 and held it in 2 quarters. The position peaked at $33.8K in Q2 2023. 37 funds tracked by Wall St. Rank hold GRTX as of Q4 2023.

  • Invesco reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Invesco sold 157,653 Galera Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $27.6K.
  • Invesco first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Invesco's Galera Therapeutics, Inc. Common Stock position peaked at $33.8K in Q2 2023.
  • 37 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.